305 related articles for article (PubMed ID: 20625108)
1. Aging-related early changes in markers of ventricular and matrix remodeling after reperfused ST-segment elevation myocardial infarction in the canine model: effect of early therapy with an angiotensin II type 1 receptor blocker.
Jugdutt BI; Jelani A; Palaniyappan A; Idikio H; Uweira RE; Menon V; Jugdutt CE
Circulation; 2010 Jul; 122(4):341-51. PubMed ID: 20625108
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction.
Jugdutt BI; Idikio H; Uwiera RR
Mol Cell Biochem; 2007 Sep; 303(1-2):27-38. PubMed ID: 17426929
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of increased secretory leukocyte protease inhibitor, matricellular proteins and angiotensin II and left ventricular remodeling by candesartan and omapatrilat during healing after reperfused myocardial infarction.
Palaniyappan A; Uwiera RR; Idikio H; Menon V; Jugdutt C; Jugdutt BI
Mol Cell Biochem; 2013 Apr; 376(1-2):175-88. PubMed ID: 23361363
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment with angiotensin receptor blockade prevents left ventricular dysfunction and blunts left ventricular remodeling associated with acute myocardial infarction.
Thai H; Castellano L; Juneman E; Phan H; Do R; Gaballa MA; Goldman S
Circulation; 2006 Oct; 114(18):1933-9. PubMed ID: 17060375
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
6. Comparison of vasopeptidase inhibitor omapatrilat and angiotensin receptor blocker candesartan on extracellular matrix, myeloperoxidase, cytokines, and ventricular remodeling during healing after reperfused myocardial infarction.
Palaniyappan A; Uwiera RR; Idikio H; Jugdutt BI
Mol Cell Biochem; 2009 Jan; 321(1-2):9-22. PubMed ID: 18777087
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.
Jugdutt BI; Menon V
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):217-26. PubMed ID: 14506547
[TBL] [Abstract][Full Text] [Related]
8. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
9. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
Suşan M; Petrescu L; Riviş AI; Suşan RM; Burghină D; Dan R; Cozma D; Drăgulescu SI
Rom J Intern Med; 2005; 43(3-4):187-98. PubMed ID: 16812979
[TBL] [Abstract][Full Text] [Related]
10. Effects of the angiotensin AT1 receptor blocker candesartan on myocardial ischemic/reperfusion injury.
Shimizu M; Sjöquist PO; Wang QD; Rydén L
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S137-42. PubMed ID: 9892154
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of satisfactory control of low-density lipoprotein cholesterol to predict left ventricular remodeling after a first ST-elevation myocardial infarction successfully reperfused.
Buono F; Spinelli L; Giallauria F; Assante di Panzillo E; Di Marino S; Ferrara F; Vigorito C; Trimarco B; Morisco C
Am J Cardiol; 2011 Jun; 107(12):1772-8. PubMed ID: 21529724
[TBL] [Abstract][Full Text] [Related]
12. Role of healing-specific-matricellular proteins and matrix metalloproteinases in age-related enhanced early remodeling after reperfused STEMI in dogs.
Jugdutt BI; Palaniyappan A; Uwiera RR; Idikio H
Mol Cell Biochem; 2009 Feb; 322(1-2):25-36. PubMed ID: 18985280
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of therapy on the progression of structural remodeling during healing after reperfused and nonreperfused myocardial infarction: different effects on different parameters.
Jugdutt BI; Menon V
J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):95-107. PubMed ID: 12075398
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-epsilon in acutely reperfused myocardial infarction in the dog. Effect of UP269-6 and losartan on AT1 and AT2-receptor expression and IP3 receptor and PKCepsilon proteins.
Xu Y; Menon V; Jugdutt BI
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):184-95. PubMed ID: 11967812
[TBL] [Abstract][Full Text] [Related]
15. Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats.
Engelhorn T; Doerfler A; Heusch G; Schulz R
Neurosci Lett; 2006 Oct; 406(1-2):92-6. PubMed ID: 16901636
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study.
Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Jeong MH; Choi DJ; Park JS; Park HS; Gwon HC
BMJ; 2014 Nov; 349():g6650. PubMed ID: 25398372
[TBL] [Abstract][Full Text] [Related]
17. AT1 receptor blockade in experimental myocardial ischemia/reperfusion.
Jalowy A; Schulz R; Heusch G
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S129-36. PubMed ID: 9892153
[TBL] [Abstract][Full Text] [Related]
18. Opposite effects of amlodipine and enalapril on infarct collagen and remodelling during healing after reperfused myocardial infarction.
Jugdutt BI; Musat-Marcu S
Can J Cardiol; 2000 May; 16(5):617-25. PubMed ID: 10833541
[TBL] [Abstract][Full Text] [Related]
19. Effects of amlodipine versus enalapril on left ventricular remodelling after reperfused anterior myocardial canine infarction.
Jugdutt BI
Can J Cardiol; 1997 Oct; 13(10):945-54. PubMed ID: 9374951
[TBL] [Abstract][Full Text] [Related]
20. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
